| Insider-Aktien | 152.417.701 shares |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Nettoanzahl der Insider, die kaufen (Rang)
Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).
Prozent des Streubesitzes von Insidern gekauft (Rang)
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
UNIVERSAL BIOSENSORS INC Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in UBI / UNIVERSAL BIOSENSORS INC getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in UBI / UNIVERSAL BIOSENSORS INC. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-11 | 3 | Mullin Peter George | UBI | Common Stock | D | 444.424 | ||||||||
| 2025-02-11 | 3 | Mullin Peter George Mullin Family Superannuation Fund | UBI | Common Stock | I | 1.519.261 | ||||||||
| 2025-02-11 | 3 | Mullin Peter George Mullin Family Trust | UBI | Common Stock | I | 577.000 | ||||||||
| 2024-05-28 | 2024-05-27 | 4 | Sharman John Stewart By wife | UBI | Common Stock | I | 0,1100 | 275.000 | 30 | 1.561.217 | ||||
| 2024-05-28 | 2024-05-27 | 4 | McLean Graham A | UBI | Common Stock | I | 0,1100 | 275.000 | 30 | 1.080.116 | ||||
| 2024-05-28 | 2024-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1100 | 1.421.293 | 156 | 87.509.318 | ||||
| 2024-05-03 | 2024-05-01 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,1500 | 217.182 | 33 | 970.802 | ||||
| 2024-05-03 | 2024-05-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1500 | 29.289.424 | 4.393 | 86.088.025 | ||||
| 2024-05-03 | 2024-05-01 | 4 | McLean Graham A | UBI | Common Stock | I | 0,1500 | 180.116 | 27 | 805.116 | ||||
| 2024-05-03 | 2024-05-01 | 4 | Sharman John Stewart By superannuation fund | UBI | Common Stock | I | 0,1500 | 30.000 | 4 | 394.666 | ||||
| 2024-05-03 | 2024-05-01 | 4 | Sharman John Stewart | UBI | Common Stock | D | 0,1500 | 23.055 | 3 | 103.055 | ||||
| 2024-05-03 | 2024-05-01 | 4 | Sharman John Stewart By wife | UBI | Common Stock | I | 0,1500 | 10.000 | 2 | 1.286.217 | ||||
| 2024-05-03 | 2024-05-01 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,1500 | 99.077 | 15 | 442.873 | ||||
| 2024-05-03 | 2024-03-25 | 4 | Sharman John Stewart | UBI | Common Stock | D | -1.000.000 | 80.000 | ||||||
| 2024-05-03 | 2024-03-25 | 4 | Sharman John Stewart By wife | UBI | Common Stock | I | 1.000.000 | 1.276.217 | ||||||
| 2024-03-26 | 2024-03-25 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2000 | 1.000.000 | 200 | 56.798.601 | ||||
| 2024-03-25 | 2024-03-25 | 4 | Sharman John Stewart | UBI | Common Stock | D | 0,2000 | 1.364.666 | 273 | 1.444.666 | ||||
| 2023-12-11 | 2023-12-11 | 4 | McLean Graham A Stock acquired by Milray Enterprises Pty Ltd ATF Graham McLean Family Trust | UBI | Common Stock | I | 0,1987 | 75.000 | 15 | 625.000 | ||||
| 2023-09-13 | 2023-09-11 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2200 | 100.000 | 22 | 753.620 | ||||
| 2023-08-21 | 2023-06-30 | 4 | Hoey David L | UBI | Common Stock | D | 0,1679 | 95.983 | 16 | 662.397 | ||||
| 2023-03-15 | 2023-03-14 | 4 | McLean Graham A | UBI | Common Stock | I | 0,2500 | 150.000 | 38 | 550.000 | ||||
| 2023-01-03 | 2023-01-01 | 4 | Balak Salesh | UBI | Common Stock | D | 50.000 | 388.558 | ||||||
| 2023-01-03 | 2023-01-01 | 4 | Sharman John Stewart | UBI | Common Stock | D | 50.000 | 80.000 | ||||||
| 2022-12-13 | 2022-12-12 | 4 | McLean Graham A | UBI | Common Stock | I | 0,2300 | 200.000 | 46 | 400.000 | ||||
| 2022-11-16 | 2022-11-16 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2400 | 17.848 | 4 | 653.620 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2400 | 82.152 | 20 | 635.772 | ||||
| 2022-11-16 | 2022-11-11 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2500 | 50.000 | 12 | 553.620 | ||||
| 2022-08-18 | 2022-08-17 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2800 | 200.000 | 56 | 503.620 | ||||
| 2022-06-21 | 2022-05-27 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,7700 | 43.796 | 34 | 343.796 | ||||
| 2022-06-15 | 2022-06-09 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,3800 | 25.000 | 10 | 303.620 | ||||
| 2022-06-01 | 2022-06-01 | 4 | McLean Graham A | UBI | Common Stock | I | 0,4600 | 96.613 | 44 | 200.000 | ||||
| 2022-06-01 | 2022-05-31 | 4 | McLean Graham A | UBI | Common Stock | I | 0,4600 | 3.387 | 2 | 103.387 | ||||
| 2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Stock Option (Right to Buy - Exercise Price $1.00) | I | 1.920.000 | 1.920.000 | ||||||
| 2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Stock Option (Right to Buy - Exercise Price $0.92) | I | 1.920.000 | 1.920.000 | ||||||
| 2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Stock Option (Right to Buy - Exercise Price $0.20) | I | 0,5700 | 1.000.000 | 570 | 1.000.000 | ||||
| 2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,4350 | 1.280.000 | 557 | 55.798.601 | ||||
| 2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,7700 | 25.893.617 | 19.938 | 54.518.601 | ||||
| 2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,7700 | 10.000 | 8 | 278.620 | ||||
| 2022-05-31 | 2022-05-24 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,4800 | 48.620 | 23 | 268.620 | ||||
| 2022-05-31 | 2022-05-27 | 4 | Sharman John Stewart By wife | UBI | Stock Option (Right to Buy) | I | 0,20 | 0,5700 | -1.000.000 | -570 | 0 | |||
| 2022-05-27 | 2022-05-27 | 4 | Balak Salesh | UBI | Common Stock | D | 0,7700 | 2.000 | 2 | 338.558 | ||||
| 2022-05-13 | 2022-05-12 | 4 | McLean Graham A Stock acquired by Graham McLean Family Trust of which Graham McLean is a member | UBI | Common Stock | I | 0,5000 | 64.962 | 32 | 100.000 | ||||
| 2022-05-13 | 2022-05-11 | 4 | McLean Graham A Stock acquired by Graham McLean Family Trust of which Graham McLean is a member | UBI | Common Stock | I | 0,5000 | 35.038 | 18 | 35.038 | ||||
| 2022-02-28 | 2022-02-24 | 4 | Balak Salesh | UBI | Common Stock | D | 30.000 | 336.558 | ||||||
| 2022-02-28 | 2022-02-24 | 4 | Sharman John Stewart | UBI | Common Stock | D | 30.000 | 30.000 | ||||||
| 2021-11-05 | 2021-11-05 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,7490 | 329.613 | 247 | 28.624.984 | ||||
| 2021-11-05 | 2021-11-03 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,7490 | 152.638 | 114 | 28.295.371 | ||||
| 2021-11-05 | 2021-11-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,7300 | 896.506 | 654 | 28.142.733 | ||||
| 2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -40.000 | 0 | |||||
| 2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Performance Rights | D | 250.000 | 250.000 | ||||||
| 2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Performance Rights | D | 500.000 | 500.000 | ||||||
| 2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Common Stock | D | 40.000 | 306.558 | ||||||
| 2021-09-14 | 2021-08-19 | 4 | Sharman John Stewart | UBI | Performance Rights | D | 1.250.000 | 1.250.000 | ||||||
| 2021-09-14 | 2021-08-19 | 4 | Sharman John Stewart | UBI | Performance Rights | D | 2.500.000 | 2.500.000 | ||||||
| 2021-09-14 | 2020-03-24 | 4 | Sharman John Stewart By wife | UBI | Stock Option (Right to Buy) | I | 0,20 | 1.000.000 | 1.000.000 | |||||
| 2021-09-14 | 2020-03-24 | 4 | Sharman John Stewart | UBI | Stock Option (Right to Buy) | D | 0,20 | -1.000.000 | 1.364.666 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | -12.559.109 | 27.246.227 | ||||||
| 2020-12-23 | 2020-12-11 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -40.000 | 0 | |||||
| 2020-12-23 | 2020-12-11 | 4 | Balak Salesh | UBI | Common Stock | D | 40.000 | 266.558 | ||||||
| 2020-11-03 | 2020-11-02 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,3100 | 200.000 | 62 | 300.000 | ||||
| 2020-09-15 | 2020-09-15 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3400 | 784.687 | 267 | 39.805.336 | ||||
| 2020-09-15 | 2020-09-14 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3300 | 80.178 | 26 | 39.020.649 | ||||
| 2020-09-15 | 2020-09-10 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3250 | 135.135 | 44 | 38.940.471 | ||||
| 2020-09-09 | 2020-09-01 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,30 | 500.000 | 500.000 | |||||
| 2020-09-08 | 2020-09-07 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3250 | 322.315 | 105 | 38.805.336 | ||||
| 2020-09-08 | 2020-09-04 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3040 | 284.962 | 87 | 38.483.021 | ||||
| 2020-09-08 | 2020-09-03 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3210 | 100.000 | 32 | 38.198.059 | ||||
| 2020-07-30 | 2020-07-27 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2500 | 730.999 | 183 | 12.559.109 | ||||
| 2020-07-30 | 2020-07-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2500 | 1.461.998 | 365 | 38.098.059 | ||||
| 2020-07-09 | 2020-07-07 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2200 | -23.820.765 | -5.241 | 0 | ||||
| 2020-06-08 | 3 | Sharman John Stewart By wife | UBI | Common Stock | I | 552.434 | ||||||||
| 2020-06-08 | 3 | Sharman John Stewart By wife | UBI | Common Stock | I | 552.434 | ||||||||
| 2020-06-08 | 3 | Sharman John Stewart By wife | UBI | Common Stock | I | 552.434 | ||||||||
| 2019-12-02 | 2019-12-02 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2000 | 119.519 | 24 | 36.636.061 | ||||
| 2019-12-02 | 2019-11-28 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2000 | 1.885.217 | 377 | 36.516.542 | ||||
| 2019-12-02 | 2019-11-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1910 | 214.783 | 41 | 34.631.325 | ||||
| 2019-11-25 | 2019-11-12 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -25.000 | 0 | |||||
| 2019-11-25 | 2019-11-12 | 4 | Balak Salesh | UBI | Common Stock | D | 25.000 | 226.558 | ||||||
| 2019-11-18 | 2019-11-15 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1900 | 36.500 | 7 | 34.416.542 | ||||
| 2019-11-18 | 2019-11-13 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1860 | 669.597 | 125 | 34.380.042 | ||||
| 2019-11-18 | 2019-11-01 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,1800 | -3.439.866 | -619 | 18.442.469 | ||||
| 2019-09-12 | 2019-09-12 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,1900 | 80.000 | 15 | 21.882.335 | ||||
| 2019-09-12 | 2019-09-11 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,1900 | 1.710.683 | 325 | 21.802.335 | ||||
| 2019-09-12 | 2019-09-12 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1900 | 80.000 | 15 | 33.710.445 | ||||
| 2019-09-12 | 2019-09-11 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1900 | 1.710.683 | 325 | 33.630.445 | ||||
| 2019-07-09 | 2019-05-29 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -73.334 | 0 | |||||
| 2019-07-09 | 2019-05-29 | 4 | Balak Salesh | UBI | Common Stock | D | 73.334 | 201.558 | ||||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -105.000 | 0 | |||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -25.000 | 0 | |||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -40.000 | 0 | |||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -40.000 | 0 | |||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 40.000 | 291.837 | ||||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 40.000 | 291.837 | ||||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 25.000 | 211.837 | ||||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 105.000 | 186.837 | ||||||
| 2019-03-06 | 2019-03-05 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2100 | 176.151 | 37 | 23.820.765 | ||||
| 2019-03-05 | 2019-03-01 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2100 | 100.000 | 21 | 23.644.614 | ||||
| 2019-01-14 | 2018-12-14 | 4 | Balak Salesh | UBI | Common Stock | D | 4.166 | 128.224 | ||||||
| 2019-01-14 | 2018-11-16 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -25.000 | 0 | |||||
| 2019-01-14 | 2018-11-16 | 4 | Balak Salesh | UBI | Common Stock | D | 25.000 | 124.058 | ||||||
| 2019-01-14 | 2018-11-16 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -25.000 | 0 | |||||
| 2019-01-14 | 2018-11-16 | 4 | Oates Adrian | UBI | Common Stock | D | 25.000 | 81.837 | ||||||
| 2019-01-14 | 2018-12-14 | 4 | Legleiter Rick L | UBI | Common Stock | D | 4.166 | 162.853 | ||||||
| 2018-12-06 | 2018-12-04 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2100 | 1.500.000 | 315 | 23.544.614 | ||||
| 2018-11-05 | 3 | CVC Ltd | UBI | Common Stock | D | 43.889.228 | ||||||||
| 2018-11-05 | 3 | CVC Ltd | UBI | Common Stock | D | 43.889.228 | ||||||||
| 2018-11-05 | 3 | CVC Ltd | UBI | Common Stock | D | 43.889.228 | ||||||||
| 2018-11-05 | 2018-10-11 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2300 | 100.000 | 23 | 22.044.614 | ||||
| 2018-05-11 | 2018-05-09 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2400 | 66.584 | 16 | 31.915.182 | ||||
| 2018-05-11 | 2018-05-09 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2400 | 66.584 | 16 | 11.823.530 | ||||
| 2018-05-08 | 2018-05-04 | 4 | Legleiter Rick L | UBI | Common Stock | D | 0,2585 | 158.687 | 41 | 158.687 | ||||
| 2018-05-07 | 2018-05-07 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2320 | 198.640 | 46 | 31.848.598 | ||||
| 2018-05-07 | 2018-05-03 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2280 | 124.305 | 28 | 31.649.958 | ||||
| 2018-05-07 | 2018-05-07 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2320 | 198.640 | 46 | 11.756.946 | ||||
| 2018-05-07 | 2018-05-03 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2280 | 124.305 | 28 | 11.558.306 | ||||
| 2018-03-19 | 2018-03-15 | 4 | Hoey David L | UBI | Common Stock | D | 0,2051 | 100.000 | 21 | 566.414 | ||||
| 2018-02-05 | 2018-02-01 | 4 | Hoey David L | UBI | Common Stock | D | 0,2300 | 116.414 | 27 | 466.414 | ||||
| 2017-12-29 | 2017-12-29 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3000 | 750.318 | 225 | 11.434.001 | ||||
| 2017-12-29 | 2017-12-28 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2940 | 50.374 | 15 | 10.683.683 | ||||
| 2017-12-29 | 2017-12-27 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2890 | 56.245 | 16 | 10.633.309 | ||||
| 2017-12-29 | 2017-12-22 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2690 | 33.613 | 9 | 10.577.064 | ||||
| 2017-12-29 | 2017-12-29 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,3000 | 2.250.953 | 675 | 20.091.652 | ||||
| 2017-12-29 | 2017-12-28 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,2940 | 151.124 | 44 | 17.840.699 | ||||
| 2017-12-29 | 2017-12-27 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,2890 | 168.737 | 49 | 17.689.575 | ||||
| 2017-12-29 | 2017-12-22 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,2690 | 100.838 | 27 | 17.520.838 | ||||
| 2017-12-29 | 2017-12-29 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3000 | 3.001.271 | 900 | 31.525.653 | ||||
| 2017-12-29 | 2017-12-28 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2940 | 201.498 | 59 | 28.524.382 | ||||
| 2017-12-29 | 2017-12-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2890 | 224.982 | 65 | 28.322.884 | ||||
| 2017-12-29 | 2017-12-22 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2690 | 134.451 | 36 | 28.097.902 | ||||
| 2017-10-26 | 2017-10-24 | 4 | Legleiter Rick L | UBI | Stock Option (Right to Buy) | D | 0,80 | 3.300.000 | 3.300.000 | |||||
| 2017-10-26 | 2017-10-24 | 4 | Legleiter Rick L | UBI | Stock Option (Right to Buy) | D | 0,60 | 2.700.000 | 2.700.000 | |||||
| 2017-10-26 | 2017-10-24 | 4 | Legleiter Rick L | UBI | Stock Option (Right to Buy) | D | 0,50 | 1.600.000 | 1.600.000 | |||||
| 2017-10-26 | 2017-10-24 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -16.667 | 0 | |||||
| 2017-10-26 | 2017-10-24 | 4 | Balak Salesh | UBI | Common Stock | D | 16.667 | 99.058 | ||||||
| 2017-10-26 | 2017-10-24 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy | D | 0,00 | -25.000 | 0 | |||||
| 2017-10-26 | 2017-10-24 | 4 | Chambers Garry | UBI | Common Stock | D | 25.000 | 2.275.594 | ||||||
| 2017-10-26 | 2017-10-24 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,00 | -25.000 | 0 | |||||
| 2017-10-26 | 2017-10-24 | 4 | Hodges Alastair | UBI | Common Stock | D | 25.000 | 2.871.615 | ||||||
| 2017-08-17 | 2017-08-16 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -16.667 | 0 | |||||
| 2017-08-17 | 2017-08-16 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -25.000 | 0 | |||||
| 2017-08-17 | 2017-08-16 | 4 | Oates Adrian | UBI | Common Stock | D | 41.667 | 56.837 | ||||||
| 2017-03-27 | 2016-12-28 | 4 | Hodges Alastair | UBI | Restricted Shares of Common Stock | D | 3.030 | 2.846.615 | ||||||
| 2017-03-27 | 2016-12-28 | 4 | Oates Adrian | UBI | Restricted Shares of Common Stock | D | 3.030 | 15.170 | ||||||
| 2017-03-27 | 2016-12-28 | 4 | Chambers Garry | UBI | Restricted Shares of Common Stock | D | 3.030 | 2.250.594 | ||||||
| 2017-03-27 | 2016-12-28 | 4 | Balak Salesh | UBI | Restricted Shares of Common Stock | D | 3.030 | 82.391 | ||||||
| 2017-03-01 | 2017-03-01 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3800 | 32.988 | 13 | 10.543.451 | ||||
| 2017-03-01 | 2017-02-28 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3850 | 247.001 | 95 | 10.510.463 | ||||
| 2017-03-01 | 2017-02-27 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3820 | 402.924 | 154 | 10.263.462 | ||||
| 2017-03-01 | 2017-03-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3800 | 32.988 | 13 | 27.963.451 | ||||
| 2017-03-01 | 2017-02-28 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3850 | 247.001 | 95 | 27.930.463 | ||||
| 2017-03-01 | 2017-02-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3820 | 402.924 | 154 | 27.683.462 | ||||
| 2017-02-17 | 2017-02-17 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,3650 | 65.000 | 24 | 100.000 | ||||
| 2017-02-17 | 2017-02-14 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,3350 | 35.000 | 12 | 35.000 | ||||
| 2017-02-16 | 2017-02-14 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3400 | 7.782 | 3 | 9.860.538 | ||||
| 2017-02-16 | 2017-02-14 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3400 | 7.782 | 3 | 27.280.538 | ||||
| 2017-01-03 | 2016-12-29 | 4 | Hodges Alastair | UBI | Restricted Shares of Common Stock | D | 3.030 | 2.846.615 | ||||||
| 2017-01-03 | 2016-12-29 | 4 | Balak Salesh | UBI | Restricted Shares of Common Stock | D | 3.030 | 82.391 | ||||||
| 2017-01-03 | 2016-12-29 | 4 | Chambers Garry | UBI | Restricted Shares of Common Stock | D | 3.030 | 2.250.594 | ||||||
| 2017-01-03 | 2016-12-29 | 4 | Oates Adrian | UBI | Restricted Shares of Common Stock | D | 3.030 | 15.170 | ||||||
| 2016-12-08 | 2016-12-06 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3347 | 16.078 | 5 | 27.272.756 | ||||
| 2016-12-08 | 2016-12-06 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3347 | 16.078 | 5 | 9.852.756 | ||||
| 2016-12-05 | 2016-12-05 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3282 | 112.009 | 37 | 27.256.678 | ||||
| 2016-12-05 | 2016-12-02 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3200 | 165.000 | 53 | 27.144.669 | ||||
| 2016-12-05 | 2016-12-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3196 | 1.807.004 | 578 | 26.979.669 | ||||
| 2016-12-05 | 2016-12-02 | 4 | VF Australian Equities Fund | UBI | Common Stock | D | 0,3200 | -154.736 | -50 | 0 | ||||
| 2016-12-05 | 2016-12-05 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3282 | 112.009 | 37 | 9.836.678 | ||||
| 2016-12-05 | 2016-12-02 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3200 | 154.736 | 50 | 9.724.669 | ||||
| 2016-12-05 | 2016-12-02 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3200 | 165.000 | 53 | 9.569.933 | ||||
| 2016-12-05 | 2016-12-01 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3196 | 1.807.004 | 578 | 9.404.933 | ||||
| 2016-09-30 | 2016-09-28 | 4 | Hoey David L | UBI | Common Stock | D | 0,2900 | 150.000 | 44 | 350.000 | ||||
| 2016-07-20 | 3 | VF Australian Equities Fund | UBI | Common Stock | D | 309.472 | ||||||||
| 2016-07-20 | 3 | VF Australian Equities Fund | UBI | Common Stock | D | 309.472 | ||||||||
| 2016-07-20 | 3 | VF High Conviction Fund | UBI | Common Stock | D | 15.195.858 | ||||||||
| 2016-07-20 | 3 | VF High Conviction Fund | UBI | Common Stock | D | 15.195.858 | ||||||||
| 2016-07-20 | 3 | VF Strategic Equities Fund | UBI | Common Stock | D | 34.840.000 | ||||||||
| 2016-07-20 | 3 | VF Strategic Equities Fund | UBI | Common Stock | D | 34.840.000 | ||||||||
| 2016-07-11 | 3 | Coleman Craig E. By the Coleman Super Fund | UBI | Common stock, par value US$0.0001 | I | 25.612.665 | ||||||||
| 2016-07-11 | 3 | Coleman Craig E. By partnership | UBI | Common stock, par value US$0.0001 | I | 50.565.330 | ||||||||
| 2016-07-11 | 3 | Coleman Craig E. By the Coleman Super Fund | UBI | Common stock, par value US$0.0001 | I | 25.612.665 | ||||||||
| 2016-07-11 | 3 | Coleman Craig E. By partnership | UBI | Common stock, par value US$0.0001 | I | 50.565.330 | ||||||||
| 2016-06-14 | 2016-06-10 | 4 | Hoey David L | UBI | Common Stock | D | 0,2900 | 200.000 | 58 | 200.000 | ||||
| 2016-02-26 | 2016-02-17 | 4 | Balak Salesh | UBI | Common Stock | D | 2.500 | 79.361 | ||||||
| 2016-02-26 | 2016-02-17 | 4 | Oates Adrian | UBI | Common Stock | D | 2.500 | 12.140 | ||||||
| 2016-02-25 | 2016-02-17 | 4 | Hodges Alastair | UBI | Common stock | D | 2.500 | 2.843.585 | ||||||
| 2016-02-19 | 2016-02-17 | 4 | Chambers Garry | UBI | Common stock | D | 2.500 | 2.247.564 | ||||||
| 2016-02-19 | 2015-12-16 | 4 | Chambers Garry | UBI | Common stock | D | 0,4500 | -100.000 | -45 | 2.245.064 | ||||
| 2016-01-14 | 2015-12-31 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,26 | -36.248 | 0 | |||||
| 2016-01-14 | 2015-12-31 | 4 | Hodges Alastair | UBI | Common Stock | D | 0,2600 | 36.248 | 9 | 2.841.085 | ||||
| 2016-01-14 | 2015-12-18 | 4 | Hodges Alastair | UBI | Common stock | D | 0,4600 | -30.000 | -14 | 2.804.837 | ||||
| 2015-07-13 | 2015-07-09 | 4 | Wright Paul | UBI | Stock Option (Right to Buy) | D | 0,00 | 60.000 | 60.000 | |||||
| 2015-07-13 | 2015-07-09 | 4 | Wright Paul | UBI | Common stock | D | 4.347 | 7.304 | ||||||
| 2015-03-02 | 2015-02-20 | 4/A | Wright Paul By Chatsworth Trust | UBI | Common stock | I | 101.819,8200 | 337.428 | 34.356.858 | 337.428 | ||||
| 2015-03-02 | 2015-02-26 | 4 | Wright Paul By Chatsworth Trust | UBI | Common stock | I | 99.812,5700 | 269.088 | 26.858.365 | 606.516 | ||||
| 2015-02-24 | 2015-02-20 | 4 | Wright Paul By Chatsworth Trust | UBI | Common stock | I | 101.819,8200 | 337.428 | 34.356.858 | 337.428 | ||||
| 2015-02-03 | 2015-01-30 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2015-02-03 | 2015-01-30 | 4 | Hodges Alastair | UBI | Common Stock | D | 4.347 | 2.834.837 | ||||||
| 2015-02-03 | 2015-01-30 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2015-02-03 | 2015-01-30 | 4 | Chambers Garry | UBI | Common Stock | D | 4.347 | 2.345.064 | ||||||
| 2015-02-03 | 2015-01-30 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2015-02-03 | 2015-01-30 | 4 | Oates Adrian | UBI | Common Stock | D | 4.347 | 9.640 | ||||||
| 2015-02-03 | 2015-01-30 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2015-02-03 | 2015-01-30 | 4 | Balak Salesh | UBI | Common Stock | D | 4.347 | 76.861 | ||||||
| 2014-06-13 | 2014-06-12 | 4 | Wright Paul | UBI | Common stock | D | 2.040 | 2.957 | ||||||
| 2014-06-13 | 2013-12-12 | 4 | Wright Paul | UBI | Stock Option (Right to Buy) | D | 0,00 | 60.000 | 60.000 | |||||
| 2014-05-16 | 2014-05-15 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver | UBI | Common Stock | I | 7.670,0000 | 50.000 | 383.500 | 2.886.340 | ||||
| 2014-05-16 | 2014-05-14 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver | UBI | Common Stock | I | 8.940,0000 | 50.000 | 447.000 | 2.836.340 | ||||
| 2014-05-14 | 2014-05-14 | 4 | Hanley Denis | UBI | Common Stock | D | 8.127,9000 | 50.000 | 406.395 | 1.918.002 | ||||
| 2014-05-13 | 2014-05-13 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver | UBI | Common Stock | I | 11.500,0000 | 50.000 | 575.000 | 2.786.340 | ||||
| 2014-05-13 | 2014-05-12 | 4 | DENVER ANDREW By wife | UBI | Common Stock | I | 6.610,5000 | 30.000 | 198.315 | 90.797 | ||||
| 2014-05-08 | 2014-05-06 | 4 | Smith Christopher M | UBI | Common Stock | D | 11.249,9500 | 30.000 | 337.498 | 30.000 | ||||
| 2014-04-16 | 2014-04-14 | 4 | Wright Paul By Macquarie Super Manager | UBI | Common Stock | I | 56.567,0800 | 142.105 | 8.038.465 | 186.771 | ||||
| 2014-01-08 | 2013-12-12 | 4 | Davis Frederick Harry | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2014-01-08 | 2013-12-12 | 4 | Davis Frederick Harry | UBI | Common Stock | D | 2.040 | 2.957 | ||||||
| 2014-01-06 | 2013-12-24 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,22 | -384.224 | 0 | |||||
| 2014-01-06 | 2013-12-24 | 4 | Hodges Alastair | UBI | Common Stock | D | 0,2200 | 384.224 | 85 | 2.830.490 | ||||
| 2014-01-06 | 2013-12-12 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2014-01-06 | 2013-12-12 | 4 | Hodges Alastair | UBI | Common Stock | D | 2.040 | 2.446.266 | ||||||
| 2014-01-06 | 2013-12-12 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2014-01-06 | 2013-12-12 | 4 | Balak Salesh | UBI | Common Stock | D | 2.040 | 72.514 | ||||||
| 2014-01-06 | 2013-12-24 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,22 | -288.168 | 0 | |||||
| 2014-01-06 | 2013-12-24 | 4 | Chambers Garry | UBI | Common Stock | D | 0,2200 | 288.168 | 63 | 2.340.717 | ||||
| 2014-01-06 | 2013-12-12 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2014-01-06 | 2013-12-12 | 4 | Chambers Garry | UBI | Common Stock | D | 2.040 | 2.052.549 | ||||||
| 2014-01-06 | 2013-12-12 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2014-01-06 | 2013-12-12 | 4 | Oates Adrian | UBI | Common Stock | D | 2.040 | 5.293 | ||||||
| 2013-10-09 | 2013-09-26 | 4 | Heinberg Marshall | UBI | Common Stock | D | 20.000 | 20.000 | ||||||
| 2013-10-04 | 2013-09-26 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Allison Denver | UBI | Common Stock | I | 200.000 | 2.736.340 | ||||||
| 2013-10-04 | 2013-09-26 | 4 | DENVER ANDREW | UBI | Common Stock | D | 28.000 | 437.050 | ||||||
| 2013-10-04 | 2013-09-26 | 4 | Hanley Denis Denis Hanley Superannuation Fund Pty Ltd | UBI | Common Stock | I | 200.000 | 954.105 | ||||||
| 2013-10-04 | 2013-09-26 | 4 | Hanley Denis Denis M Hanley Pty Ltd | UBI | Common Stock | I | 6.000 | 54.889 | ||||||
| 2013-10-04 | 2013-09-26 | 4 | Hanley Denis | UBI | Common Stock | D | 29.772 | 1.868.002 | ||||||
| 2013-06-11 | 2013-06-11 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,22 | -384.224 | 384.224 | |||||
| 2013-06-11 | 2013-06-11 | 4 | Hodges Alastair | UBI | Common Stock | D | 84.529,2800 | 384.224 | 32.478.178 | 2.444.226 | ||||
| 2013-06-11 | 2013-06-11 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,22 | -288.168 | 288.168 | |||||
| 2013-06-11 | 2013-06-11 | 4 | Chambers Garry | UBI | Common Stock | D | 63.396,9600 | 288.168 | 18.268.975 | 2.050.509 | ||||
| 2013-05-28 | 2013-05-27 | 4 | Wright Paul | UBI | Common Stock | D | 917 | 917 | ||||||
| 2013-05-28 | 2012-11-13 | 4 | Wright Paul | UBI | Stock Option (Right to Buy) | D | 0,00 | 37.500 | 37.500 | |||||
| 2013-02-20 | 2013-02-12 | 4 | Oates Adrian | UBI | Common Stock | D | 7.291,3800 | -8.333 | -60.759 | 3.253 | ||||
| 2013-01-08 | 2012-05-16 | 4 | DENVER ANDREW | UBI | Common Stock | I | 378.645,6800 | 676.153 | 256.022.412 | 2.536.340 | ||||
| 2013-01-08 | 2012-05-16 | 4 | DENVER ANDREW By spouse | UBI | Common Stock | I | 378.645,6800 | -676.153 | -256.022.412 | 60.797 | ||||
| 2013-01-08 | 2012-05-15 | 4 | DENVER ANDREW | UBI | Common Stock | I | 379.890,0000 | 678.375 | 257.707.879 | 1.860.187 | ||||
| 2013-01-08 | 2012-05-15 | 4 | DENVER ANDREW | UBI | Common Stock | D | 379.890,0000 | -678.375 | -257.707.879 | 409.050 | ||||
| 2012-12-28 | 2012-12-18 | 4 | Wilson Elizabeth | UBI | Common Stock | I | 3.999,6000 | 4.444 | 17.774 | 2.035.944 | ||||
| 2012-12-28 | 2012-12-19 | 4 | Balak Salesh | UBI | Common Stock | D | 1.999,8000 | 2.222 | 4.444 | 70.474 | ||||
| 2012-12-28 | 2012-12-18 | 4 | Wright Paul By Macquarie Super Manager | UBI | Common Stock | I | 14.999,4000 | 16.666 | 249.980 | 44.666 | ||||
| 2012-11-23 | 2012-11-13 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,00 | 25.000 | 25.000 | |||||
| 2012-11-23 | 2012-11-13 | 4 | Hodges Alastair | UBI | Common Stock | D | 917 | 2.060.002 | ||||||
| 2012-11-23 | 2012-11-13 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | 25.000 | 25.000 | |||||
| 2012-11-23 | 2012-11-13 | 4 | Oates Adrian | UBI | Common Stock | D | 917 | 11.586 | ||||||
| 2012-11-23 | 2012-11-13 | 4 | Davis Frederick Harry | UBI | Stock Option (Right to Buy) | D | 0,00 | 25.000 | 25.000 | |||||
| 2012-11-23 | 2012-11-13 | 4 | Davis Frederick Harry | UBI | Common Stock | D | 917 | 917 | ||||||
| 2012-11-21 | 2012-11-13 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | 25.000 | 25.000 | |||||
| 2012-11-21 | 2012-11-13 | 4 | Balak Salesh | UBI | Common Stock | D | 917 | 68.252 | ||||||
| 2012-11-21 | 2012-11-13 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,00 | 25.000 | 25.000 | |||||
| 2012-11-21 | 2012-11-13 | 4 | Chambers Garry | UBI | Common Stock | D | 917 | 1.762.341 | ||||||
| 2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -8.333 | 0 | |||||
| 2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -8.333 | 0 | |||||
| 2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -21.666 | 73.334 | |||||
| 2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Common Stock | D | 38.332 | 67.335 | ||||||
| 2012-08-27 | 2012-08-23 | 4 | Davis Frederick Harry By wife | UBI | Common Stock | I | 0,7000 | 23.376 | 16 | 28.747 | ||||
| 2012-08-27 | 2012-08-22 | 4 | Davis Frederick Harry By wife | UBI | Common Stock | I | 0,7000 | 5.371 | 4 | 5.371 | ||||
| 2012-03-06 | 2012-02-27 | 4 | Hodges Alastair | UBI | Common Stock | D | 0,7300 | -1.000.000 | -730 | 2.059.085 | ||||
| 2012-01-24 | 2011-03-07 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -25.000 | -36 | 17.431.617 | ||||
| 2012-01-24 | 2011-03-04 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -24.000 | -34 | 17.456.617 | ||||
| 2012-01-24 | 2011-03-03 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -10.000 | -14 | 17.480.617 | ||||
| 2012-01-24 | 2011-03-01 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -34 | -0 | 17.490.617 | ||||
| 2012-01-24 | 2011-02-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -1.083 | -2 | 17.490.651 | ||||
| 2012-01-24 | 2011-02-25 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -2.590 | -4 | 17.491.734 | ||||
| 2012-01-24 | 2011-02-23 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | -37.279 | -57 | 17.494.324 | ||||
| 2012-01-24 | 2011-02-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | -5.000 | -7 | 17.531.603 | ||||
| 2012-01-24 | 2011-02-17 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3500 | -5.000 | -7 | 17.536.603 | ||||
| 2012-01-24 | 2011-02-16 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | -5.000 | -7 | 17.541.603 | ||||
| 2012-01-24 | 2011-02-15 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | -5.000 | -7 | 17.546.603 | ||||
| 2012-01-24 | 2011-02-11 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3800 | -22.463 | -31 | 17.551.603 | ||||
| 2012-01-24 | 2011-02-09 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | -22 | -0 | 17.574.066 | ||||
| 2012-01-24 | 2011-02-08 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3700 | -10.000 | -14 | 17.574.088 | ||||
| 2012-01-24 | 2011-02-07 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3800 | -50.000 | -69 | 17.584.088 | ||||
| 2012-01-24 | 2011-02-02 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5300 | -50.000 | -76 | 17.589.088 | ||||
| 2012-01-24 | 2011-02-01 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | -50.000 | -76 | 17.639.088 | ||||
| 2012-01-24 | 2011-01-31 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5000 | -50.000 | -75 | 17.689.088 | ||||
| 2012-01-24 | 2011-01-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | -50.000 | -76 | 17.739.088 | ||||
| 2012-01-24 | 2011-01-27 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | -17.869 | -27 | 17.789.088 | ||||
| 2012-01-24 | 2011-01-25 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | -73 | -0 | 17.806.957 | ||||
| 2012-01-24 | 2011-01-24 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | -50.000 | -76 | 17.807.030 | ||||
| 2012-01-24 | 2011-01-21 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | -50.000 | -76 | 17.857.030 | ||||
| 2012-01-24 | 2011-01-20 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | -50.000 | -76 | 17.907.030 | ||||
| 2012-01-24 | 2011-01-19 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | -50.000 | -76 | 17.957.030 | ||||
| 2012-01-24 | 2011-01-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | -50.000 | -76 | 18.007.030 | ||||
| 2012-01-24 | 2011-01-14 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4800 | -50.000 | -74 | 18.057.030 | ||||
| 2012-01-24 | 2011-01-13 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5000 | -50.000 | -75 | 18.107.038 | ||||
| 2012-01-24 | 2011-01-12 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4900 | -50.000 | -74 | 18.157.030 | ||||
| 2012-01-24 | 2011-09-08 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 0,9600 | -1.500.000 | -1.440 | 15.749.937 | ||||
| 2012-01-24 | 2011-08-01 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,1900 | -752 | -1 | 17.249.937 | ||||
| 2012-01-24 | 2011-07-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3000 | -341 | -0 | 17.250.689 | ||||
| 2012-01-24 | 2011-04-29 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5300 | -10.000 | -15 | 17.251.030 | ||||
| 2012-01-24 | 2011-04-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | -10.000 | -15 | 17.261.030 | ||||
| 2012-01-24 | 2011-04-27 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | -10.000 | -15 | 17.271.030 | ||||
| 2012-01-24 | 2011-04-21 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4900 | -35.000 | -52 | 17.281.030 | ||||
| 2012-01-24 | 2011-04-20 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4400 | -10.000 | -14 | 17.316.030 | ||||
| 2012-01-24 | 2011-04-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -8.000 | -11 | 17.326.030 | ||||
| 2012-01-24 | 2011-04-15 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -7.500 | -11 | 17.334.030 | ||||
| 2012-01-24 | 2011-04-14 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4100 | -10.000 | -14 | 17.341.530 | ||||
| 2012-01-24 | 2011-03-30 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3900 | -155 | -0 | 17.351.530 | ||||
| 2012-01-24 | 2011-03-29 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3800 | -32 | -0 | 17.351.685 | ||||
| 2012-01-24 | 2011-03-21 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | -4.900 | -7 | 17.351.717 | ||||
| 2012-01-24 | 2011-03-10 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4000 | -25.000 | -35 | 17.356.617 | ||||
| 2012-01-24 | 2011-03-09 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -25.000 | -36 | 17.381.617 | ||||
| 2012-01-24 | 2011-03-08 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4100 | -25.000 | -35 | 17.406.617 |
